Hope Pharmaceuticals (Scottsdale, Ariz) recently announced the release of Sodium Nitrite Injection USP 3% in singledose vials. This product is indicated for the treatment of cyanide poisoning. It is a primary component of the Cyanide Antidote Kit, which is used by hospitals and public safety authorities for emergency preparedness. Cyanide inhalation can cause severe toxic effects and death within minutes to hours. Prompt treatment is critical for patient survival. The new vials facilitate rapid administration during an emergency. For more information, visit www.hopepharm.com.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs